FDA Mulls Baldness Pill
From Washington Post
WASHINGTON — A cure for baldness--in a pill?
That tantalizing possibility may have moved a step closer to reality Thursday when a Food and Drug Administration advisory committee reviewed a drug that Merck & Co. wants to market for baldness.
The drug, finasteride, would be marketed under the brand name Propecia if approved by the FDA. The drug has been shown in clinical trials to prevent further hair loss and increase hair growth in many users.
More to Read
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.